Skip to main content

Table 4 Total, median, and mean acquisition cost of antifungals (US Dollars)

From: Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study

 

AMB Period (n = 255)1

AZ Period (n = 317)1

 

n2

Total Cost3

Median Cost4

Mean Cost4

n2

Total Cost3

Median Cost4

Mean Cost4

AMB

254

$119,194

$70 ($65–$76)

$467 ($274–$661)

198

$36,129

$18 ($9–$27)

$113 ($40–$186)

FLU

33

$8,343

0

$29 ($2–$56)

228

$78,849

$173 ($108–$224)

$245 ($211–$278)

VOR

4

$10,485

0

$34 ($0–$76)

160

$216,559

$75 (0–$250)

$682 ($563–$802)

CASPO

7

$17,228

0

$66 ($11–$122)

43

$174,718

0

$537 ($333–$741)

ITRA

50

$7,984

0

$29 ($19–$40)

6

$833

0

$3 ($0–$5)

Total

348

$164,405

$70

$630

645

$507,175

$266

$1,577

  1. 1Number of hospitalizations with available charges
  2. 2Number of hospitalizations with charges for the individual antifungals
  3. 3All costs are rounded to the nearest dollar
  4. 4Median or mean cost (lower 95% confidence interval to upper 95% confidence interval). Reported means are least squared means from mixed effects regression models that controlled for the number of hospitalizations
  5. Note: AMB = amphotericin; AZ = Azole; FLU = fluconazole; VOR = voriconazole; CASPO = caspofungin; ITRA = itraconazole